World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 27

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3609)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

196

HTML

2414

Sum=2610

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

193

Download

566

Sum=759

Jul 21, 2024 (publication date) through Feb 26, 2026

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	McGinty G, Przemioslo R. Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications. World J Gastroenterol 2024; 30(27): 3264-3267 [PMID: 39086753 DOI: 10.3748/wjg.v30.i27.3264]
URL:	https://www.wjgnet.com/1948-5204/full/v30/i27/3264.htm

Number	Citing Articles
1	Ling Luo, Congxiang Shao, Long Teng, Shuyu Zhuo, Zhi Dong, Wei Wang, Junzhao Ye, Bihui Zhong. Liver fibrosis with persistently normal alanine transaminase levels exhibits a distinct treatment response in MASLD. BMJ Open Gastroenterology 2025; 12(1): e001895 doi: 10.1136/bmjgast-2025-001895
2	Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening test. World Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576 Abstract(556) \| Core Tip(644) \| Full Article(HTML)(1794) \| Full Article with Cover (PDF)-644K(302) \| Audio-887K(7) \| Peer-Review Report-177K(105) \| Answering Reviewers-110K(103) \| Full Article (PDF)-421K(126) \| Full Article (XML)-115K(94) \| Times Cited (4) \| Total Visits (4382) \| Open
3	Can Huang, Meng Chen, Yanfang Sun, Lin Zhang, Wei Liu. Research trends on the quality of life in patients with metabolic dysfunction-associated fatty liver diseases: a scientific metrology study. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1689280
4	Jingli Zhu, Hai He, Yingli Li, Yichu Li, Zhenghu Feng, Jiaxue Yuan, Liang Liu, Qisheng Shen, Jiayinaer Baishan, Tianzhu Song, Zhiqiang Li. Metabolomic characteristics and mechanisms of subgingival plaque in MASLD patients with periodontitis. Metabolomics 2026; 22(2) doi: 10.1007/s11306-026-02400-0
5	Zhi Peng, Zijin Wang, Juan Wang, Xuefeng Li. Hepatic steatosis/fibrosis related biomarkers in patients with metabolic dysfunction-associated steatotic liver disease. Biomarkers in Medicine 2025; 19(23): 1239 doi: 10.1080/17520363.2025.2595909